Protein target identifi cation of ginsenosides in skeletal muscle tissues: discovery of natural smallmolecule activators of muscle-type creatine kinase|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Ginseng effectively reduces fatigue in both animal models and clinical trials. However, themechanism of action is not completely understood, and its molecular targets remain largely unknown.
Methods: By screening for proteins that interact with the primary components of ginseng (ginsenosides)in an affinity chromatography assay, we have identified muscle-type creatine kinase (CK-MM) as a potentialtarget in skeletal muscle tissues.
Results: Biolayer interferometry analysis showed that ginsenoside metabolites, instead of parent ginsenosides,had direct interaction with recombinant human CK-MM. Subsequently, 20(S)-protopanaxadiol(PPD), which is a ginsenoside metabolite and displayed the strongest interaction with CK-MM in thestudy, was selected as a representative to confirm direct binding and its biological importance. Biolayerinterferometry kinetics analysis and isothermal titration calorimetry assay demonstrated that PPDspecifically bound to human CK-MM. Moreover, the mutation of key amino acids predicted by moleculardocking decreased the affinity between PPD and CK-MM. The direct binding activated CK-MM activityin vitro and in vivo, which increased the levels of tissue phosphocreatine and strengthened the functionof the creatine kinase/phosphocreatine system in skeletal muscle, thus buffering cellular ATP, delayingexercise-induced lactate accumulation, and improving exercise performance in mice.
Conclusion: Our results suggest a cellular target and an initiating molecular event by which ginsengreduces fatigue. All these findings indicate PPD as a small molecular activator of CK-MM, which can helpin further developing better CK-MM activators based on the dammarane-type triterpenoid structure.

번역하기

참고문헌 (Reference)

1 Strickland EC, "Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation" 8 : 148-161, 2013

2 백인호, "The world ginseng market and the ginseng (Korea)" 고려인삼학회 37 (37): 1-7, 2013

3 Rask-Andersen M, "The druggable genome : evaluation of drug targets in clinial trials suggests major shifts in molecular class and indication" 54 : 9-26, 2014

4 Wallimann T, "The creatine kinase system and pleiotropic effects of creatine" 40 : 1271-1296, 2011

5 Koch AJ, "The creatine kinase response to resistance exercise" 14 : 68-77, 2014

6 Sahlin K, "The creatine kinase reaction : a simple reaction with functional complexity" 40 : 1363-1367, 2011

7 Lahiri SD, "The 2. 1 Åstructure of Torpedo californica creatine kinase complexed with the ADPMg2+-NO3--creatine transition-state analogue complex" 41 : 13861-13867, 2002

8 Lomenick B, "Target identification using drug affinity responsive target stability(DARTS)" 106 : 21984-21989, 2009

9 Futamura Y, "Target identification of small molecules based on chemical biology approaches" 9 : 897-914, 2013

10 Ziegler S, "Target identification for small bioactive molecules : finding the needle in the haystack" 52 : 2744-2792, 2013